AC Immune SA financial data

Symbol
ACIU on Nasdaq
Location
1015 Lausanne, Switzerland
Fiscal year end
31 December
Latest financial report
20-F - Q4 2025 - 13 Mar 2026

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101,742,231 shares 1.3%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense CHF16,826,000 CHF -1.8%
General And Administrative Expense CHF3,896,000 CHF -14%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets CHF154,251,000 CHF -33%
Liabilities CHF109,367,000 CHF -7.8%